Combined kidney and hematopoeitic cell transplantation to induce mixed chimerism and tolerance
- PMID: 31431706
- PMCID: PMC8185903
- DOI: 10.1038/s41409-019-0603-4
Combined kidney and hematopoeitic cell transplantation to induce mixed chimerism and tolerance
Abstract
Based on preclinical studies, combined kidney and hematopoietic cell transplantation was performed on fully HLA matched and haplotype matched patients at the Stanford University Medical Center. The object of the studies was to induce mixed chimerism, immune tolerance, and complete immunosuppressive drug withdrawal. Tolerance, persistent mixed chimerism, and complete withdrawal was achieved in the majority of fully matched patients. Persistent mixed chimerism and partial withdrawal has been achieved in the haplotype matched patients at present.
Conflict of interest statement
References
-
- Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis. 2014;63(Suppl 1):A7. - PubMed
-
- Suthanthiran M, Strom TB. Renal transplantation. New Engl J Med. 1994;331:365–76. - PubMed
-
- Marcen R Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009;69:2227–43. - PubMed
-
- Srinivas TR, Schold JD, Guerra G, Eagan A, Bucci CM, Meier-Kriesche HU. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant. 2007;7:586–94. - PubMed
-
- Cecka JM. The UNOS Scientific Renal Transplant Registry–ten years of kidney transplants. Clin Transplant, 1997;1–14. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
